Learn how erenumab (Aimovig), a CGRP receptor‑blocking monoclonal antibody, differs from traditional migraine drugs like beta‑blockers and antidepressants. Explore its targeted mechanism, once‑monthly dosing, and clinical trial results for episodic and chronic migraine prevention.
Learn what bempedoic acid is, how it works as a non‑statin LDL‑lowering therapy, its liver‑selective mechanism of action, and key clinical evidence from phase 3 and CLEAR Outcomes trials in statin‑intolerant, high‑risk patients.
Explore how generative AI is reshaping small molecule drug discovery—from latent chemical spaces and graph neural networks to AI-designed compounds now advancing in oncology, CNS, and rare disease pipelines.
Discover how AI-powered pharmacovigilance is transforming drug safety with always-on monitoring, advanced pattern detection, and real-world data integration—from unstructured case narratives to EHRs, wearables, and patient voices. Learn what “good” AI-first safety looks like and how to adopt it without sacrificing scientific rigor or regulatory trust.
Learn how tirzepatide, a dual GLP‑1/GIP agonist, improves blood sugar control and drives double‑digit weight loss. Discover its mechanism, clinical benefits for type 2 diabetes, and its emerging role in obesity treatment.
Discover how tirzepatide, a first-in-class dual GIP and GLP‑1 receptor agonist, is redefining obesity care with surgery-level weight loss, improved glucose control, and powerful multi-organ metabolic benefits.
Discover how AI and machine learning are transforming pharmacovigilance by automating case processing, enhancing signal detection, and enabling predictive drug safety. Learn about NLP for unstructured safety data, ML models for triage and coding, and the ethical challenges of AI in adverse event monitoring.
Learn how PROTAC small molecule drugs are redefining cancer therapy by degrading, not just inhibiting, oncogenic proteins. Explore the PROTAC mechanism, their role in expanding the druggable cancer proteome, and their potential to overcome resistance in precision oncology.
Discover how AI-driven pharmacovigilance is revolutionizing drug safety by mining EHRs, claims data, social media, and wearables for real-time signal detection, risk evaluation, and smarter benefit–risk decisions for pharma, regulators, and safety scientists.
Learn what retatrutide is, how this triple‑agonist (GLP‑1, GIP, glucagon) injectable works, and why early clinical trial data suggest it may rival bariatric surgery for weight loss and cardiometabolic benefits.